Chemical Formula: C21H32O3
Chemical Formula C21H32O3
Found 451 metabolite its formula value is C21H32O3
Oxymetholone
A - Alimentary tract and metabolism > A14 - Anabolic agents for systemic use > A14A - Anabolic steroids > A14AA - Androstan derivatives D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D045930 - Anabolic Agents D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D000728 - Androgens C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C2360 - Anabolic Steroid
17alpha,20alpha-Dihydroxypregn-4-en-3-one
17 alpha,20alpha-Dihydroxypregn-4-en-3-one, also known as 17,20 alpha-OHP or 20alpha-dihydroxyprogesterone, is a steroid hormone that is elevated in late pregnancy. In particular, the concentration of plasma 17,20 alpha-OHP is significantly increased during the third trimester of pregnancy, and the increment continues to increase through labour and delivery (PMID:6874891). 17,20 alpha-OHP is known to be a substrate for the enzyme 20alpha-hydroxysteroid dehydrogenase or 20alpha-HSD (EC 1.1.1.149). This enzyme catalyzes the following chemical reaction: 17alpha,20alpha-dihydroxypregn-4-en-3-one + NAD(P)+ = 17alpha-hydroxyprogesterone + NAD(P)H + H+. This enzyme is actively involved in the control of progesterone homeostasis in the pregnancy of mammals. While 20alpha-HSD expression and activity is downregulated in the corpus luteum of pregnancy, 24 hours prior to parturition, ovarian 20alpha-HSD activity is acutely stimulated. 17,20 alpha-OHP is a biologically weaker progestin. Progestin facilitates estrogen induction of the preovulatory luteinizing hormone (LH) surge. It is known that 17,20 alpha-OHP is increased at midcycle but its importance in regulating LH has not been studied. However, periovulatory levels of 17,20 alpha-OHP do not play a role in modulating the estrogen-induced bioactive LH surge (PMID:2245841). 17 alpha, 20 alpha-dihydroxy-4-pregnen-3-one (17 alpha, 20 alpha-OHP) is a steroid hormone that is elevated in late pregnancy. In particular, the concentration of plasma 17,20 alpha-OHP is significantly increased during the third trimester of pregnancy, and the increment continues to increase through labor and delivery (PMID: 6874891). 17 alpha, 20 alpha-dihydroxy-4-pregnen-3-one is known to be a substrate for the enzyme 20a-hydroxysteroid dehydrogenase or 20alpha-HSD (EC 1.1.1.149). This enzyme catalyzes the chemical reaction: 17alpha,20alpha-dihydroxypregn-4-en-3-one + NAD(P)+ = 17alpha-hydroxyprogesterone + NAD(P)H + H+. This enzyme is actively involved in the control of progesterone homeostasis in pregnancy of mammals. While 20alpha-HSD expression and activity is downregulated in the corpus luteum of pregnancy, 24 hrs prior to parturition ovarian 20alpha-HSD activity is acutely stimulated. [HMDB]
17a-Hydroxypregnenolone
17a-Hydroxypregnenolone is a 21-carbon steroid that is converted from pregnenolone by cytochrome P450 17alpha hydroxylase/C17,20 lyase (CYP17, EC 1.14.99.9). 17a-Hydroxypregnenolone is an intermediate in the delta-5 pathway of biosynthesis of gonadal steroid hormones and the adrenal corticosteroids. The first, rate-limiting and hormonally regulated step in the biosynthesis of all steroid hormones is the conversion of cholesterol to pregnenolone. The conversion of cholesterol to pregnenolone is accomplished by the cleavage of the cholesterol side chain, catalyzed by a mitochondrial cytochrome P450 enzyme termed P450scc where scc designates Side Chain Cleavage. All steroid hormones are made from the pregnenolone produced by P450scc; thus, the presence or absence of each of the activities of CYP17 directs this pregnenolone towards its final metabolic pathway. While all cytochrome P450 enzymes can catalyze multiple reactions on a single active site, CYP17 is the only one described to date in which these multiple activities are differentially regulated by a physiologic process. 17a-Hydroxypregnenolone is converted to dehydroepiandrosterone by the 17,20 lyase activity of CYP17. The ratio of the 17,20 lyase to 17 alpha-hydroxylase activity of CYP17 determines the ratio of C21 to C19 steroids produced. This ratio is regulated post-translationally by at least three factors: the abundance of the electron-donating protein P450 oxidoreductase, the presence of cytochrome b5, and the serine phosphorylation of CYP17. (PMID: 12573809). C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones 17a-Hydroxypregnenolone is a pregnane steroid. 17a-Hydroxypregnenolone is a prohormone in the formation of dehydroepiandrosterone (DHEA).
21-hydroxypregnenolone
21-hydroxypregnenolone is an essential intermediate in corticosterone synthesis. The hydrolysis of 21-hydroxypregnenolone of fetal origin by steryl-sulfatase (SOS, EC 3.1.6.2), may be important in the biosynthesis of deoxycorticosterone, which is present in the plasma of pregnant women in high concentration. 21-hydroxypregnenolone has been identified in follicular fluid from follicles of women. Pregnenolone is transformed to 21-hydroxypregnenolone by human adrenal microsomal preparations, suggesting the involvement of alternative paths via 17a,21-dihydroxypregnenolone in human. (PMID 974176, 3347051, 3495701, 7382480, 6247575) [HMDB] 21-hydroxypregnenolone is an essential intermediate in corticosterone synthesis. The hydrolysis of 21-hydroxypregnenolone of fetal origin by steryl-sulfatase (SOS, EC 3.1.6.2), may be important in the biosynthesis of deoxycorticosterone, which is present in the plasma of pregnant women in high concentration. 21-hydroxypregnenolone has been identified in follicular fluid from follicles of women. Pregnenolone is transformed to 21-hydroxypregnenolone by human adrenal microsomal preparations, suggesting the involvement of alternative paths via 17a,21-dihydroxypregnenolone in human. (PMID 974176, 3347051, 3495701, 7382480, 6247575). D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones 21-Hydroxypregnenolone. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=1164-98-3 (retrieved 2024-07-16) (CAS RN: 1164-98-3). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). 21-Hydroxypregnenolone is an essential intermediate in corticosterone synthesis.
16-a-Hydroxypregnenolone
16-alpha-hydroxypregnenolone, also known as 16A OH-Preg or (3beta,16alpha)-3,16-dihydroxypregn-5-en-20-one, is classified as a gluco/mineralocorticoid, a progestogin or aprogestogin derivative. Gluco/mineralocorticoids are steroids with a structure based on a hydroxylated prostane moiety. Thus, 16-alpha-hydroxypregnenolone is a steroid or more correctly a 16alpha-hydroxy steroid. 16-alpha-hydroxypregnenolone is also classified as a hydroxypregnenolone. A hydroxypregnenolone is a pregnenolone substituted by an alpha-hydroxy group at position 16. It is a steroid molecule that is produced by all vertebrates. In humans, 16-alpha-hydroxypregnenolone can be found primarily in blood, urine and in human umbilical cord tissue. 16-alpha-Hydroxypregnenolone is a normal urinary metabolite with increased total excretion in newborn infants with congenital adrenal hyperplasia due to 21-hydroxylase deficiency (PMID 6980322). It is therefore an important urinary marker for the occurrence of an adrenal 21-hydroxylase-deficiency. Its levels are an indication for the effectiveness of medication (cortisol supplement) against this disease. (PMID: 10399855). 16-a-Hydroxypregnenolone is a normal urinary metabolite with increased total excretion in newborn infants with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. (PMID 6980322) [HMDB] D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
alfaxalone
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics N - Nervous system > N01 - Anesthetics > N01A - Anesthetics, general C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent D018377 - Neurotransmitter Agents > D000081227 - Neurosteroids
11beta,17beta-Dihydroxy-6alpha,17-dimethylandrost-4-en-3-one
11alpha,17beta-Dihydroxy-2alpha,17-dimethylandrost-4-en-3-one
11beta-Hydroxy-4,17-dimethyltestosterone
7alpha-Hydroxypregnenolone
This compound belongs to the family of Gluco/mineralocorticoids, Progestogins and Derivatives. These are steroids whose structure is based on an hydroxylated prostane moiety. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
5alpha-Dihydrodeoxycorticosterone
This compound belongs to the family of Gluco/mineralocorticoids, Progestogins and Derivatives. These are steroids whose structure is based on an hydroxylated prostane moiety.
[10]-Shogaol
[10]-Shogaol is found in ginger. [10]-Shogaol is isolated from ginger (Zingiber officinale) [DFC] (Yannai, Shmuel. (2004) Dictionary of food compounds with CD-ROM: Additives, flavors, and ingredients. Boca Raton: Chapman & Hall/CRC. [10]-Shogaol is a monomethoxybenzene, a member of phenols and an enone. [10]-Shogaol is a natural product found in Zingiber officinale with data available. See also: Ginger (part of). Isolated from ginger (Zingiber officinale) [DFC]. [10]-Shogaol is found in ginger. [10]-Shogaol is an antioxidant from Zingiber officinale for human skin cell growth and a migration enhancer. [10]-Shogaol inhibits COX-2 with an IC50 of 7.5 μM and has antiproliferation activity[1][2][3]. [10]-Shogaol is an antioxidant from Zingiber officinale for human skin cell growth and a migration enhancer. [10]-Shogaol inhibits COX-2 with an IC50 of 7.5 μM and has antiproliferation activity[1][2][3].
(15alpha,20R)-15,20-Dihydroxypregn-4-en-3-one
(15alpha,20R)-15,20-Dihydroxypregn-4-en-3-one is found in fats and oils. (15alpha,20R)-15,20-Dihydroxypregn-4-en-3-one is a constituent of the aglycone from Carthamus tinctorius (safflower).
5beta-dihydrodeoxycorticosterone
5beta-dihydrodeoxycorticosterone, also known as Hydroxydione or 21-Hydroxy-5beta-pregnane-3,20-dione, is classified as a member of the 21-hydroxysteroids. 21-hydroxysteroids are steroids carrying a hydroxyl group at the 21-position of the steroid backbone. 5beta-dihydrodeoxycorticosterone is considered to be practically insoluble (in water) and relatively neutral D018377 - Neurotransmitter Agents > D000081227 - Neurosteroids
(20R)-17,20-Dihydroxypregn-4-en-3-one
16-Hydroxypregnenolone
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
3,17-Dihydroxypregn-5-en-20-one
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones 17a-Hydroxypregnenolone is a pregnane steroid. 17a-Hydroxypregnenolone is a prohormone in the formation of dehydroepiandrosterone (DHEA).
(5R,8R,9S,10S,13S,14S,17S)-17-(2-Hydroxyacetyl)-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one
Dihydroxy-4-pregnen-3-one
oxymetholone
(8S,9S,10R,13S,14S,17S)-17-(1,1-Dihydroxyethyl)-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
2beta,3beta-Dihydroxy-5alpha-pregn-17(E)-en-16-one
Methyl ent-16-hydroxy-6,8(17),13E-labdatrien-15-oate
2alpha-Methoxy-3alpha,4alpha-epoxy-ent-cleroda-13(16),14-diene-15,16-oxide
2beta,3beta-Dihydroxy-5alpha-pregn-17(Z)-en-16-one
4(18),13-Clerodadien-3-oxo-15-oic acid methyl ester
3-Oxo-21-nor-5alpha-pregnansaeure-(20)-methylester|3-Oxo-5alpha-androstan-17beta-carbonsaeure-methylester|3-oxo-5alpha-androstane-17beta-carboxylic acid methyl ester|methyl 3-oxo-5alpha-androstane-17beta-carboxylate
methyl (E)-14xi,15-epoxylabd-8(17),12-dien-16-oate
carbomethoxyfuscol|methyl (1R*,2R*,4S*)-18-hydroxyloba-8,10,13(Z),16(E)-tetraen-13-carboxylate
(3beta,14beta)-form-3,14-Dihydroxypregn-5-en-20-one
6beta,11alpha-Dihydroxy-3alpha,5alpha-cyclopregnan-20-on
methyl 15-hydroxyabietate|monomethyl 15-hydroxyabietate
2alpha,3beta-dihydroxy-16-oxopregn-5(6)-ene|dyscusin B
Me ester-2-[(2,3,3a,4,5,7a-Hexahydro-3,6-dimethyl-2-benzofuranyl)ethylidene]-6-methyl-5-heptenoic acid
14-(3-Furanyl)-3, 7, 11-trimethyl-7, 11-tetradecadienoic acid
grandiflorolic acid methyl ester|Grandiflorolsaeure-methylester (15alpha-Hydroxy-(-)-Delta16-kauren-19-saeure-methylester)|methyl 15alpha-hydroxykaur-16-en-19-oate|methyl ent-15beta-hydroxy-16-kauren-19-oate|methyl ent-15beta-hydroxy-kaur-16-en-19-oate|methyl ent-15beta-hydroxykaur-16-en-19-oate|methyl grandiflolate
(3R,2E)-2-(hexadec-15-ynyliedene)-3-hydroxy-4-methylenebutanolide|3E-Isomer-Mahubynolide|??|isomahubynolide
ent-12beta-hydroxykaurenoic acid methyl ester|methyl ent-12beta-hydroxykaur-16-en-19-oate
16-oxocleroda-3,13(14)E-dien-15-oic acid methyl ester
3-(7,10-hexadecadienylidene)dihydro-4-hydroxy-5-methylene-2(3h)-furanone
3alpha-Hydroxy-ent-kaurensaeuremethylester|methyl 3alpha-hydroxy-ent-kaur-16-en-19-oate|methyl ent-3beta-hydroxy-kaur-16-en-19-oate
14-Deoxy, 17-Me ether-17, 18-Epoxy-1(19), 7, 10, 12-xenicatetraene-6, 14, 17-triol
(2R*,3R*,6E,9E,10R*,18S*)-7,18-18,19-bisepoxyxenic-19-methoxy-6,9,13-triene
(13E)-2-oxoneocleroda-3,13-dien-15-oate|2-oxokolavenic acid methyl ester|Altissimsaeure-methylester|methyl (2E)-3-methyl-5-[(1S,2R,4aR,8aR)-1,2,3,4,4a,7,8,8a-octahydro-1,2,4a,5-tetramethyl-7-oxonaphthalen-1-yl]pent-2-enoate|methyl 2-oxo-kolavenoate|methyl 2-oxokolavenoate|methyl-2-oxo-kolavenoate
Methyl 7alpha-hydroxy-ent-pimara-8,15-dien-19-oate
agallochin O|agallocin O|methyl ent-17-hydroxy-3,4-secokaura-4(19),15-dien-3-oate
(3Z,12Z)-6,7:9,10:15,16-trisepoxyhenicosa-3,12,20-triene|6,7;12,13:15,16-Triepoxide-(all-Z)-1,6,9,12,15,18-Heneicosahexaene
methyl 9-hydroxyl-eicosa-2(Z),5(Z),7(E),11(Z),14(Z)-pentaenoate
5alpha-methoxy-1betaH,2alphaH-casba-3Z,7E,11E-trien-18-oic acid|pekinenin B
(-)-(1R*,4R*,10R*)-4-methoxycembra-2E,7E,11Z-trien-20,10-olide
15-methoxylabda-8(17),13-dien-15,15-olide|coronarin G
7S,8S-epoxy-1,3,11-cembratriene-16-oic methyl ester
methyl 15-oxopimara-8(14)-en-18-oate|Methyl-15-oxo-8(14)-pimaren-18-oat
3beta,12beta-dihydroxy-5alpha-pregnane-16-en-20-one
methyl 12R-hydroxymethyl-8(17),11Z,13(16)-trien-19-oate
6,7,8,9-Tetrahydro-2-methoxy-3-isopropyl-8-[3-[2-(hydroxymethyl)oxirane-2-yl]propyl]-5H-benzocycloheptene
Me ester-(5Z,7E,9E,14Z,11S,12S)-11,12-Epoxy-5,7,9,14-eicosatetraenoic acid
6alpha-15,16-Epoxy-6-hydroxy-7,13(16),14-labdatrien-17-oic acid
3beta,14beta-dihydroxy-17betaH-pregn-5-en-15-one|stemmin C
17alpha-Hydroxy-pregnenolon|3-beta,17-alpha-dihydroxypregn-4-en-20-one
chrisolic acid methyl ester|Me ester-Chrysolic acid|methyl chrysolate
2alpha-hydroxy-12,13Z-ozic acid methylester|Me ester-(ent-2beta,12Z)-2-Hydroxy-8(17)-,12,14-labdatrien-18-oic acid
19-Aldehydo-8(17),E-13-labdadien-15-oat|methyl agathalate|Methyl-19-aldehydo-8(17)-(E)-13-labdadien-15-oat
Et ester-(5Z,8R,9E,11Z,14Z,17Z)-8-Hydroxy-5,9,11,14,17-eicosapentaenoic acid
Me ester-(2Z,5Z,7E,11Z,14Z)-9-Hydroxy-2,5,7,11,14-eicosapentaenoic acid
Me ester-(ent-15beta)-15-Hydroxy-19-trachylobanoic acid
2-Methyl-2-(4-methyl-3-pentenyl)-7-pentyl-3,4-dihydro-2H-1-benzopyran-3,5-diol
(12S)-hydroxyeicosapentaenoic acid|12-(S)-HEPE methyl ester
Me ester-3beta-3-Hydroxy-7,15-isopimaradien-18-oic acid
Me ester-(ent-13E)-15-Oxo-1(10),13-halimadien-18-oic acid|methyl 15-al-1(10),13Z-ent-halimadien-18-oate
Me ester-2-[(3,4,4a,5,6,8a-Hexahydro-4,7-dimethyl-2H-1-benzofuran-2-yl)methylene]-6-methyl-5-heptenoic acid
Me ester-(5Z,8Z,10E,12E,14S,15S)-14,15-Epoxy-5,8,10,12-eicosatetraenoic acid
[(3S,8R,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
(E)-1-(4-hydroxy-3-methoxyphenyl)tetradec-4-en-3-one
C21H32O3_(3R,4R,5R)-3-[(11E)-11,15-Hexadecadien-9-yn-1-yl]-4-hydroxy-5-methyldihydro-2(3H)-furanone
17a-Hydroxypregnenolone
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones A hydroxypregnenolone carrying an alpha-hydroxy group at position 17. 17-α-hydroxypregnenolone, also known as (3beta)-3,17-dihydroxypregn-5-en-20-one or 5-pregnen-3b,17a-diol-20-one, belongs to gluco/mineralocorticoids, progestogins and derivatives class of compounds. Those are steroids with a structure based on a hydroxylated prostane moiety. Thus, 17-α-hydroxypregnenolone is considered to be a steroid lipid molecule. 17-α-hydroxypregnenolone is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 17-α-hydroxypregnenolone can be found in a number of food items such as strawberry guava, java plum, conch, and chives, which makes 17-α-hydroxypregnenolone a potential biomarker for the consumption of these food products. 17-α-hydroxypregnenolone can be found primarily in blood, as well as in human adrenal cortex and testes tissues. In humans, 17-α-hydroxypregnenolone is involved in a couple of metabolic pathways, which include androgen and estrogen metabolism and steroidogenesis. 17-α-hydroxypregnenolone is also involved in several metabolic disorders, some of which include aromatase deficiency, adrenal hyperplasia type 3 or congenital adrenal hyperplasia due to 21-hydroxylase deficiency, adrenal hyperplasia type 5 or congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency, and apparent mineralocorticoid excess syndrome. 17a-Hydroxypregnenolone is a pregnane steroid. 17a-Hydroxypregnenolone is a prohormone in the formation of dehydroepiandrosterone (DHEA).
(5Z,7E)-(1S,3R,20S)-9,10-seco-5,7,10(19)-pregnatriene-1,3,20-triol
17-DHP
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
10-shogaol
[10]-Shogaol is an antioxidant from Zingiber officinale for human skin cell growth and a migration enhancer. [10]-Shogaol inhibits COX-2 with an IC50 of 7.5 μM and has antiproliferation activity[1][2][3]. [10]-Shogaol is an antioxidant from Zingiber officinale for human skin cell growth and a migration enhancer. [10]-Shogaol inhibits COX-2 with an IC50 of 7.5 μM and has antiproliferation activity[1][2][3].
(15alpha,20R)-15,20-Dihydroxypregn-4-en-3-one
ST 21:2;O3
A hydroxypregnenolone that is pregnenolone substituted by a alpha-hydroxy group at position 16. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone 17a-Hydroxypregnenolone is a pregnane steroid. 17a-Hydroxypregnenolone is a prohormone in the formation of dehydroepiandrosterone (DHEA). 21-Hydroxypregnenolone is an essential intermediate in corticosterone synthesis.
hydroxydione
D018377 - Neurotransmitter Agents > D000081227 - Neurosteroids
1-cyclohexyl-4,4-diethoxy-2-methyl-2-phenylbutan-1-one
p-propoxyphenyl trans-4-pentylcyclohexanecarboxylate
(1R,2R,3aS,9aS)-2,3,3a,4,9,9a-Hexahydro-1-[(3S)-3-hydroxyoctyl]-1H-benz[f]indene-2,5-diol
16 Alpha,17-epoxy-3 beta-hydroxy-5 alpha-pregnan-20-one
17,21-Dihydroxypregn-4-en-3-one
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
17beta-Carbomethoxyandrost-5-en-3beta-ol
[(1S,5S,8S,9S,10S,13S,14S,17S)-1-Hydroxy-10,13-dimethyl-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
20-alfa-Dhydrodydrogesterone
The (20S)-stereoisomer of 17,20-dihydroxypregn-4-en-3-one. 20 alpha-dihydroxyprogesterone is a biologically weaker progestin. Progestin facilitates estrogen induction of the preovulatory luteinizing hormone (LH) surge. It is known that 20 alpha-dihydroxyprogesterone is increased at midcycle but its importance in regulating LH has not been studied. Howevever periovulatory levels of 20 alpha-dihydroxyprogesterone do not play a role in modulating the estrogen-induced bioactive LH surge. (PMID:2245841) [HMDB]
(5R,8R,9S,10S,13S,14S,17S)-17-(2-Hydroxyacetyl)-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one
(20S)-1alpha,20-dihydroxy-22,23,24,25,26,27-hexanorvitamin D3/(20S)-1alpha,20-dihydroxy-22,23,24,25,26,27-hexanorcholecalciferol
(8S,9S,10R,13S,14S,17S)-17-(1,1-Dihydroxyethyl)-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
4-Pregnen-20,21-diol-3-one
A 3-oxo Delta(4)-steroid that is pregn-4-en-3-one carrying two hydroxy substituents at positions 20 and 21. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
rel-(-)-(1R,4R,10R)-4-methoxycembra-2E,7E,11Z-trien-20,10-olide
A cembrane diterpenoid that is cembra-2E,7E,11Z-trien-20,10-olide substituted by a methoxy group at position 4. It has been isolated from the leaves of Croton gratissimus.
(3R,4R,5R)-3-[(11E)-hexadeca-11,15-dien-9-ynyl]-4-hydroxy-5-methyloxolan-2-one
(5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-3-oxo-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-2-carboxaldehyde
17-Hydroxy-17-methyl-3-oxoandrostane-2-carbaldehyde
(3R,5S,8R,9R,10S,13S,14S,17S)-17-acetyl-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-one
(4AS,5S,8AS)-(-)-5beta,8Abeta-dimethyl-2-ethylenedioxymethyl-5alpha-(4-methyl-3-pentenyl)-4A,5,6,7,8,8aalpha-hexahydronaphthalen-1(4H)-one
7alpha-Hydroxypregnenolone
A 20-oxo steroid that is pregnenolone carrying an additional hydroxy substituent at the 7alpha-position. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
5beta-dihydrodeoxycorticosterone
A 3-oxo-5beta-steroid formed from 11-deoxycorticosterone by reduction across the C4-C5 double bond.
21-hydroxypregnenolone
A hydroxypregnenolone that is pregnenolone which has been substituted by a hydroxy group at position 21. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones 21-Hydroxypregnenolone is an essential intermediate in corticosterone synthesis.
(20R)-17,20-Dihydroxypregn-4-en-3-one
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
7beta-hydroxypregnenolone
A 20-oxo steroid that is pregnenolone carrying an additional hydroxy substituent at the 7beta-position.
(1z,3as,3br,5as,7r,8s,9as,9bs,11as)-1-ethylidene-7,8-dihydroxy-9a,11a-dimethyl-dodecahydro-3h-cyclopenta[a]phenanthren-2-one
(1r,4ar,4br,6s,10ar)-7-isopropyl-6-methoxy-1,4a-dimethyl-2,3,4,4b,5,6,10,10a-octahydrophenanthrene-1-carboxylic acid
2-methoxy-11-methyl-7-(4-methylpent-3-en-1-yl)-3,5-dioxatricyclo[6.6.1.0⁴,¹⁵]pentadeca-1(14),11-diene
methyl (1s,4s,5s,6r,9s,10r,13r)-6-hydroxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate
methyl (1's,2r,4's,5'r,9's,10's,13'r)-5',9'-dimethylspiro[oxirane-2,14'-tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane]-5'-carboxylate
methyl 3-hydroxy-3-methyl-5-(3,4,8,8-tetramethyl-6,7-dihydro-5h-naphthalen-2-yl)pentanoate
2-[(1r,2s,4r,5s,9r,10s,13r)-2-hydroxy-5-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-14-yl]acetaldehyde
methyl 5-(2-formyl-1,4,5,7a-tetramethyl-3a,5,6,7-tetrahydro-3h-inden-4-yl)-3-methylpent-2-enoate
methyl (1r,4s,5s,6r,9s,10s,13s)-6-hydroxy-5,9,13-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-ene-5-carboxylate
(1r,4ar,4br,6s,10as)-7-isopropyl-6-methoxy-1,4a-dimethyl-2,3,4,4b,5,6,10,10a-octahydrophenanthrene-1-carboxylic acid
2-[(2-hydroxy-2,5,5,8a-tetramethyl-hexahydro-1h-naphthalen-1-yl)methyl]benzene-1,4-diol
(4r,7r,13s)-4-isopropyl-7-methoxy-7,11-dimethyl-14-oxabicyclo[11.2.1]hexadeca-1(16),5,10-trien-15-one
(1e,3as,3br,5as,7r,8s,9as,9bs,11as)-1-ethylidene-7,8-dihydroxy-9a,11a-dimethyl-dodecahydro-3h-cyclopenta[a]phenanthren-2-one
3-{2-[(1s,4as,8as)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]ethylidene}-5-methoxyoxolan-2-one
methyl 6-hydroxy-5,9,13-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-ene-5-carboxylate
methyl 14-hydroxy-5,9,14-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-11-ene-5-carboxylate
methyl (1s,4s,5r,9s,10s,13r)-14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-ene-5-carboxylate
(1r,3ar,7z,7ar)-7-ethylidene-6-[(1s)-1,3,3-trimethylcyclohexyl]-3,3a,4,7a-tetrahydro-1h-2-benzofuran-1-yl acetate
methyl (2e)-4-[(1s,4as,8as)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-2-[(2r)-oxiran-2-yl]but-2-enoate
(3z,4r)-3-(hexadec-15-yn-1-ylidene)-4-hydroxy-5-methylideneoxolan-2-one
7-isopropyl-6-methoxy-1,4a-dimethyl-2,3,4,4b,5,6,10,10a-octahydrophenanthrene-1-carboxylic acid
3-(2-hydroxypropan-2-yl)-8-methoxy-3a,6,9-trimethyl-1h,2h,3h,4h,5h,6h,10bh-benzo[e]azulen-2-ol
(1z,3as,3br,5ar,7r,8s,9as,9bs,11as)-1-ethylidene-7,8-dihydroxy-9a,11a-dimethyl-dodecahydro-3h-cyclopenta[a]phenanthren-2-one
methyl 7-ethenyl-6-hydroxy-1,4a,7-trimethyl-3,4,4b,5,6,9,10,10a-octahydro-2h-phenanthrene-1-carboxylate
(1r,6s,7as)-6-{1-[(1e)-2,2-dimethylcyclopentylidene]ethyl}-7,7-dimethyl-4,5,6,7a-tetrahydro-1h-2-benzofuran-1-yl acetate
(3r,5s)-3-[(9z)-hexadeca-9,15-dien-7-yn-1-yl]-5-(hydroxymethyl)oxolan-2-one
2-methyl-2-(4-methylpent-3-en-1-yl)-7-pentyl-3,4-dihydro-1-benzopyran-3,5-diol
4-hydroxy-3,5-dimethyl-6-[(2z,4e,6s,8s)-4,6,8-trimethylundeca-2,4-dien-2-yl]pyran-2-one
methyl 2-{4,10,14-trimethyl-15-oxabicyclo[12.1.0]pentadeca-4,6,10-trien-7-yl}propanoate
2-isopropyl-3-methoxy-4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthrene-4,9-diol
10-deoxy-4,18-epoxy-12-methoxy-4,5-seco-pisiferan-19-ol
{"Ingredient_id": "HBIN000104","Ingredient_name": "10-deoxy-4,18-epoxy-12-methoxy-4,5-seco-pisiferan-19-ol","Alias": "NA","Ingredient_formula": "C21H32O3","Ingredient_Smile": "CC(C)C1=C(C=C2CC(CCCC2=C1)CCCC3(CO3)CO)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5169","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
15,20-dihydroxypregn-4-en-3-one
{"Ingredient_id": "HBIN001581","Ingredient_name": "15,20-dihydroxypregn-4-en-3-one","Alias": "NA","Ingredient_formula": "C21H32O3","Ingredient_Smile": "CC(C1CC(C2C1(CCC3C2CCC4=CC(=O)CCC34C)C)O)O","Ingredient_weight": "332.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9300","PubChem_id": "129682610","DrugBank_id": "NA"}
15alpha,20beta-dihydroxy-delta4-pregnen-3-one
{"Ingredient_id": "HBIN001606","Ingredient_name": "15alpha,20beta-dihydroxy-delta4-pregnen-3-one","Alias": "NA","Ingredient_formula": "C21H32O3","Ingredient_Smile": "CC(C1CC(C2C1(CCC3C2CCC4=CC(=O)CCC34C)C)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25876","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
15α,20β-dihydroxy-Δ4-pregnen-3-one
{"Ingredient_id": "HBIN001607","Ingredient_name": "15\u03b1,20\u03b2-dihydroxy-\u03944-pregnen-3-one","Alias": "NA","Ingredient_formula": "C21H32O3","Ingredient_Smile": "CC(C1CC(C2C1(CCC3C2CCC4=CC(=O)CCC34C)C)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15128","TCMID_id": "6100","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
15-methoxy-abietic acid
{"Ingredient_id": "HBIN001695","Ingredient_name": "15-methoxy-abietic acid","Alias": "NA","Ingredient_formula": "C21H32O3","Ingredient_Smile": "CC12CCCC(C1CC=C3C2CCC(=C3)C(C)(C)OC)(C)C(=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "34169","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1β-hydroxypisiferanol
{"Ingredient_id": "HBIN002417","Ingredient_name": "1\u03b2-hydroxypisiferanol","Alias": "NA","Ingredient_formula": "C21H32O3","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10656","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3β-acetoxy-17β-hydroxy-androst-5-ene
{"Ingredient_id": "HBIN008137","Ingredient_name": "3\u03b2-acetoxy-17\u03b2-hydroxy-androst-5-ene","Alias": "NA","Ingredient_formula": "C21H32O3","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "205","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
4(18),13-clerodadien-3-oxo-15-oicacid methylester
{"Ingredient_id": "HBIN009837","Ingredient_name": "4(18),13-clerodadien-3-oxo-15-oicacid methylester","Alias": "NA","Ingredient_formula": "C21H32O3","Ingredient_Smile": "CC1CCC2(C(C1(C)CCC(=CC(=O)OC)C)CCC(=O)C2=C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "3835","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5β-H-pregnan-3,20-dione
{"Ingredient_id": "HBIN011466","Ingredient_name": "5\u03b2-H-pregnan-3,20-dione","Alias": "NA","Ingredient_formula": "C21H32O3","Ingredient_Smile": "CC(=O)C1CCC2C1(CC(=O)C3C2CCC4C3(CCC(C4)O)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "42023","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5β-H-pregnan-3α-ol-20-oneglucoside
{"Ingredient_id": "HBIN011467","Ingredient_name": "5\u03b2-H-pregnan-3\u03b1-ol-20-oneglucoside","Alias": "NA","Ingredient_formula": "C21H32O3","Ingredient_Smile": "CC(=O)C1CCC2C1(CC(=O)C3C2CCC4C3(CCC(C4)O)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "36693","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5β-H-pregnan-3β-ol-20-one
{"Ingredient_id": "HBIN011468","Ingredient_name": "5\u03b2-H-pregnan-3\u03b2-ol-20-one","Alias": "NA","Ingredient_formula": "C21H32O3","Ingredient_Smile": "CC(=O)C1CCC2C1(CC(=O)C3C2CCC4C3(CCC(C4)O)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "36691","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
agallochin o
{"Ingredient_id": "HBIN014813","Ingredient_name": "agallochin o","Alias": "NA","Ingredient_formula": "C21H32O3","Ingredient_Smile": "CC(=C)C1CCC23CC(CCC2C1(C)CCC(=O)OC)C(=C3)CO","Ingredient_weight": "332.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "695","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "12085703","DrugBank_id": "NA"}